The activation of CB2 appears to protect the brain and its functions from damage under neuroinflammatory actions, making it an attractive target in a variety of neurological conditions such as Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and Huntington’s disease.
Cannabis and Inflammation: Clinical Mechanisms
How cannabinoids reduce inflammatory markers
The endocannabinoid receptor CB2 is a regulator of trauma-inducing anxiety and a potential target for PTSD drugs
Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear In Summary Researchers recently identified a signaling pathway in the endocannabinoid system that regulates...
Cannabinoid receptor type 2 as a promising new target for schizophrenia drugs
Contribution of CB2 receptors in schizophrenia-related symptoms in various animal models In Summary Schizophrenia is a serious, chronic mental disorder that disrupts how a person thinks, feels and behaves. Its psychotic (also...